ISSN

0974-4150 (Online)
0974-4169 (Print)


Author(s): Gupta A., Chaturvedi P., Shrivastava S. K., Dubey P.K

Email(s): gakanksha09@gmail.com

DOI: Not Available

Address: Gupta A. *, Chaturvedi P., Shrivastava S. K. and Dubey P.K
Swami Vivekananda College of Pharmacy, Near Toll Naka, Khandwa Road, Indore-452020
Corresponding author

Published In:   Volume - 5,      Issue - 2,     Year - 2012


ABSTRACT:
Diabetes mellitus is a heterogenous group of diseases, characterized by a state of chronic hyperglycemia, resulting from a diversity of etiologies, environmental and genetic, acting jointly. The underlying causes of diabetes are the controls of carbohydrate, fat and protein metabolism. Characterstically diabetes is a long-term disease with variable clinical manifestations and progression, chronic hyperglycemia from whatever cause, leads to a number of complications including cardiovascular such as hypertension, renal, neurological such as anxiety, stress, ocular and other such inter-current infections. Glitazones are used as oral hypoglycemic agents used in diabetes in both combinations with other categories and single because of their targeted site of action these glitazones were used. Glitazones are also known as thaizolidinediones(TZD). Glitazones are agonists for the peroxisome proliferator-activated receptor, PPAR? which regulates the transcription of insulin responsive genes involved in control of glucose production, transport, and utilization. Currently, there are several classes of drugs that are used to manage Type 2 diabetes. However, only the thiazolidinediones (TZDs) have been shown to consistently improve estimates of ß- cell function. By improving insulin sensitivity and potentially preserving ß-cell function, the TZDs are able to provide durable glycemic control. The TZDs also have been found to reduce inflammatory markers, improve vascular function and lipid profiles, and decrease blood pressure in patients with Type 2 diabetes, which may improve long-term cardiovascular outcomes. This reveals that the glitazones used in diabetes because to their targetted site of action it is very useful and effective than other classes of oral hypoglycemics agents.


Cite this article:
Gupta A. , Chaturvedi P., Shrivastava S. K., Dubey P.K. Glitazones for the Treatment of Diabetes Type-2. Asian J. Research Chem. 5(2): February 2012; Page 164-170.


Recomonded Articles:

Author(s): Sabale Prafulla, Potey Lata, Rahangdale Priya, Sabale Vidya

DOI: 10.5958/0974-4150.2019.00011.7         Access: Open Access Read More

Author(s): Shashikant P. Pawar, Tryambakrao J. Patil, Ratnamala S. Bendre

DOI: 10.5958/0974-4150.2018.00003.2         Access: Open Access Read More

Author(s): Tiwari Preeti, Patel RK

DOI:         Access: Open Access Read More

Author(s): N V L Suvarchala Reddy V, Sneha J Anarthe, Ganga Raju M, Akhila M, Pooja Raj G.B.

DOI: 10.5958/0974-4150.2019.00020.8         Access: Open Access Read More

Author(s): K S Chandrashekharaiah, H P Shweta, Rajiv Bharadwaj, N G Raju, N. Ramachandra Swamy

DOI: 10.5958/0974-4150.2018.00063.9         Access: Open Access Read More

Author(s): Sushil R. Mathapati, Vikas B. Suryawanshi,Abhay S. Bondge,Jairaj K. Dawale

DOI: 10.5958/0974-4150.2018.00044.5         Access: Open Access Read More

Author(s): S. J. Daharwal, S Prakash Rao, Vijay Kumar Singh, Chandraprakash Dwivedi, Veena D. Singh

DOI: 10.5958/0974-4150.2015.00070.X         Access: Open Access Read More

Author(s): Prarthana V Rewatkar, Ganesh R Kokil

DOI:         Access: Open Access Read More

Author(s): Nikhat F., Satyanarayana D., Purohit M.G., Bharat, Moid A.

DOI:         Access: Open Access Read More

Author(s): Sorimuthu Pillai Subramanian, Gopalan Sriram Prasath

DOI:         Access: Open Access Read More

Author(s): Karthik Dhananjayan, Arunachalam Sumathy, Sivanandy Palanisamy

DOI:         Access: Open Access Read More

Author(s): T. Sharanya Nair, Meghana R, Shlini P

DOI: 10.5958/0974-4150.2019.00037.3 9         Access: Closed Access Read More

Author(s): Jaya Tripathi, Manoj Kumar Mahto, Divya R., Prof. M. Bhaskar, Sajad Shahbazi

DOI:         Access: Open Access Read More

Asian Journal of Research in Chemistry (AJRC) is an international, peer-reviewed journal devoted to pure and applied chemistry..... Read more >>>

RNI: Not Available                     
DOI: 10.5958/0974-4150 

Popular Articles


Recent Articles




Tags